分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Mesenchymal stem cells inhibit MRP-8/14 expression and neutrophil migration via TSG-6 in the treatment of lupus nephritis

Lingli Zhang, Weiwei Chen, Nan Xia, Dan Wu, Honghong Yu, Yuanyuan Zheng, Hongwei Chen, Fei Fei, Linyu Geng, Xin Wen, Shanshan Liu, Dandan Wang, Jun Liang, Wei Shen, Ziyi Jin, Xiaojing Li, Genhong Yao

Journal:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

IF:3.1

DOI:10.1016/j.bbrc.2023.02.005

PMID:36791546

Published:2023-02-03

research field:分子生物学微生物学食品科学病毒学

Abstract

Abnormal infiltration and activation of neutrophils play a pathogenic role in the development of lupus nephritis (LN). Myeloid-related proteins (MRPs), MRP-8 and -14, also known as the damage-associated molecular patterns (DAMPs), are mainly secreted by activated neutrophils in systemic lupus erythematosus (SLE). Mesenchymal stem cells (MSCs) regulate a variety of immune cells to treat LN, but it is not clear whether MSCs can regulate neutrophils and the expression of MRP-8/14 in LN. Here, we demonstrated that neutrophil infiltration and MRP-8/14 expression were increased in the kidney of MRL/lpr mice and both decreased after MSCs transplantation . Further, the results showed that tumor necrosis factor- (TNF) stimulated gene-6 (TSG-6) in MSCs is necessary for MSCs to inhibit MRP-8/14 expression in neutrophils and neutrophil migration. In addition, small-molecule immunosuppressant had no significant effect on the expression of MRP-8/14 in neutrophils. Therefore, our results suggest that MSCs inhibited MRP-8/14 expression and neutrophil migration by secreting TSG-6 in the treatment of LN.

本文使用的Yeasen产品

购物车
客服
转染试用